Onco Interventional Radiology (IR) procedures provide targeted, minimally invasive treatment for cancer, especially liver tumours. These include TACE (Trans-Arterial Chemoembolization), TARE (Trans-Arterial Radioembolization), and Microwave Ablation (MWA) for hepatocellular carcinoma (HCC). These therapies help control tumour growth, preserve healthy tissue, and improve patient outcomes with reduced hospital stay and recovery time.
TACE
Trans-Arterial Chemoembolization (TACE) is a minimally invasive treatment for liver cancer (HCC). During this operation, a chemotherapeutic drug is injected directly into the blood vessel that supplies the tumor, and the blood flow to the malignancy is subsequently restricted to help shrink or manage the tumor. It is carried out with a tiny catheter put via the blood vessels under image guidance. TACE improves cancer treatment while minimizing damage to good liver tissue and avoiding major surgery.
TARE
TARE (Trans-Arterial Radioembolization) is a minimally invasive treatment for liver cancer, namely Hepatocellular Carcinoma (HCC). In this method, tiny radioactive particles are given directly into the blood arteries that nourish the tumor, assisting in the destruction of cancer cells while sparing the majority of healthy liver tissue. The treatment is carried out using a tiny catheter injected into the blood vessels under picture guidance. TARE controls tumor development, improves symptoms, and may increase survival with less discomfort and a faster recovery than major surgery.
MWA (Microwave ablation) : for liver cancer (HCC)
Microwave Ablation (MWA) is a minimally invasive treatment for liver cancer (HCC) in which heat from microwave energy is utilized to kill cancer cells. Using imaging guidance, a thin needle is inserted directly into the tumour, heating and treating the cancer tissue without the need for extensive surgery. This surgery slows tumour growth, protects healthy liver tissue, shortens recovery time, and allows patients to resume regular activities sooner.
